Cibc World Markets Corp Elanco Animal Health Inc Transaction History

Cibc World Markets Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$14.37 - $16.46 $490,146 - $561,434	34,109 New	34,109 $555,000
Q4 2022 Feb 09, 2023	SELL	$11.49 - $13.65 $14.2 Million - $16.8 Million	-1,232,300 Reduced 55.2%	1,000,000 $12.2 Million
Q1 2020 May 12, 2020	BUY	$16.68 - $32.25 $35.8 Million - $69.3 Million	2,149,200 Added 2586.28%	2,232,300 $50 Million
Q4 2019 Feb 13, 2020	BUY	$25.29 - $29.45 $2.1 Million - $2.45 Million	83,100 New	83,100 $2.45 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

Stay updated on Cibc World Markets Corp with notifications on news.